AGP Picks
View all

Allergy treatment market seen reaching $35.63 billion by 2030

Oct. 30, 2026
Allergy treatment market seen reaching $35.63 billion by 2030
By AI, Created 14:15 UTC, Oct 30, 2026, AGP -

The global allergy treatment market is projected to grow from $24.74 billion in 2025 to $35.63 billion by 2030, driven by rising allergy rates, broader treatment access and growing use of immunotherapy. North America led in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Rising allergy rates are expanding demand for medicines, immunotherapy and care settings that can diagnose and manage symptoms. - The market forecast signals continued growth for drugmakers, clinics, pharmacies and digital sales channels serving allergy patients. - The trend also reflects more cases of asthma and rhinitis tied to allergic disease.

What happened: - The Business Research Company projected the global allergy treatment market will grow from $24.74 billion in 2025 to $26.56 billion in 2026. - The report forecasts the market will reach $35.63 billion by 2030. - The company said the market is expected to post a 7.3% CAGR from 2025 to 2026 and a 7.6% CAGR from 2026 to 2030. - The report was published under The Business Research Company’s Allergy Treatment Global Market Report 2026. - The source text includes a free sample of the market report. - The source text also includes the full market report.

The details: - Growth in 2025 and 2026 is linked to rising allergy prevalence worldwide. - Expanded treatment offerings at hospitals and clinics are supporting market growth. - Limited awareness of advanced immunotherapy options continues to shape treatment choices. - Ongoing reliance on conventional antihistamines remains a factor in the market. - Retail pharmacy networks are widening access to allergy treatments. - Future growth is expected to come from personalized allergy care, delivery improvements in immunotherapy, online pharmacy sales and more investment in allergy research. - The report also points to stronger demand from pediatric and adult asthma and rhinitis cases. - Expected trends include wider use of anti-allergy medications and immunotherapy, more homecare and specialty clinic services, customized treatment plans, and greater use of nasal and oral drug delivery. - Allergy treatment covers medications and immunotherapies designed to reduce symptoms, improve quality of life and limit future allergic responses.

Between the lines: - The market outlook suggests allergy care is shifting from symptom control toward more tailored treatment approaches. - Growth in online pharmacy channels and homecare services points to more decentralized access to allergy treatment. - The report’s regional split shows mature demand in North America and faster expansion potential in Asia-Pacific. - Allergy UK reported in April 2024 that more than 21 million people in the UK suffer from allergies, and the condition was the most commonly reported chronic health condition in 2022. - Projections in the source text say half of Europe’s population will experience at least one allergy by 2026.

What's next: - The market is expected to keep expanding as allergy diagnoses rise and treatment options broaden. - The Asia-Pacific region is projected to be the fastest-growing market over the forecast period. - The report highlights updated tools for 2026, including TAM analysis, company scoring matrices, forecasting dashboards, hotspots infographics and future trend analysis. - The Business Research Company listed Saumya Sahay as a contact for more information, along with regional phone numbers and marketing@tbrc.info.

The bottom line: - Allergy treatment is becoming a larger global market, with growth tied to rising patient counts, broader access to care and a move toward more personalized therapy.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

UK Daily Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

UK Daily Ledger

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.